Market Value5,467,231,000
Total Holdings70
File Date2020-11-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
STRO / Sutro Biopharma, Inc.
WVE / Wave Life Sciences Ltd.
/ Pandion Therapeutics Inc
ARYBU / ARYA Sciences Acquisition Corp II
US60877T1007 / Momenta Pharmaceuticals, Inc.
AVDL / Avadel Pharmaceuticals plc
US74140Y1010 / Prevail Therapeutics Inc.
CLDX / Celldex Therapeutics, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
SELB / Selecta Biosciences Inc
BDTX / Black Diamond Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
VXRT / Vaxart, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
FMTX / Forma Therapeutics Holdings Inc
AXSM / Axsome Therapeutics, Inc.
ARDX / Ardelyx, Inc.
RPTX / Repare Therapeutics Inc.
LYRA / Lyra Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
TGTX / TG Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
STSA / Satsuma Pharmaceuticals Inc
AKUS / Akouos Inc
GRTX / Galera Therapeutics, Inc.
GMTX / Gemini Therapeutics Inc
OCUL / Ocular Therapeutix, Inc.
MGNX / MacroGenics, Inc.
OVID / Ovid Therapeutics Inc.
RLMD / Relmada Therapeutics, Inc.
ZGNX / Zogenix Inc
INZY / Inozyme Pharma, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
NAUT / Nautilus Biotechnology, Inc.
STOK / Stoke Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
CRDF / Cardiff Oncology, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
VSTM / Verastem, Inc.
SLDB / Solid Biosciences Inc.
NVAX / Novavax, Inc.
PMVP / PMV Pharmaceuticals, Inc.
XFOR / X4 Pharmaceuticals, Inc.
CCXI / Churchill Capital Corp XI
PASG / Passage Bio, Inc.
MCRB / Seres Therapeutics, Inc.
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
TRIL / Tidal Trust II - Defiance Trillion Dollar Club Index ETF
CNCE / Concert Pharmaceuticals Inc
ADVM / Adverum Biotechnologies, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
SCPH / scPharmaceuticals Inc.
MIST / Milestone Pharmaceuticals Inc.
KALA / KALA BIO, Inc.
LRMR / Larimar Therapeutics, Inc.
ARVN / Arvinas, Inc.
ETNB / 89bio, Inc.
ITOS / iTeos Therapeutics, Inc.
INBX.V / Inhibrx, Inc.
IGMS / IGM Biosciences, Inc.
DYN / Dyne Therapeutics, Inc.
ALEC / Alector, Inc.
NKTX / Nkarta, Inc.
ASND / Ascendis Pharma A/S
IMGN / ImmunoGen, Inc.
PCVX / Vaxcyte, Inc.
INSM / Insmed Incorporated
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation